Study guide

2.5 Liver Function Tests, Bilirubin Metabolism, and Jaundice

Philippine Medical Technologists Licensure Examination MTLE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Clinical Chemistry: Laboratory Operations, Instrumentation, Reagents, Quality Assurance, and Safety

1.1 Specimen Collection, Preanalytical Variables, and Interferences 1.2 Clinical Chemistry Instrumentation, Photometry, and Automation 1.3 Quality Control, Westgard Rules, Calibration, and Laboratory Mathematics 1.4 Reagent Preparation, Laboratory Water, Glassware, Pipettes, and Centrifuges 1.5 Laboratory Safety: Chemical, Fire, Electrical, Biological, and Physical Hazards

2 Chapter 2: Clinical Chemistry: Carbohydrates, Lipids, Proteins, Non-Protein Nitrogen, and Liver Function

2.1 Glucose Homeostasis, Diagnostic Criteria for Diabetes Mellitus, and Glycemic Monitoring 2.2 Lipids, Lipoproteins, Apolipoproteins, and Coronary Heart Disease Risk Assessment 2.3 Serum Proteins, Albumin, Globulins, and Serum Protein Electrophoresis Patterns 2.4 Non-Protein Nitrogen Compounds: Urea, Creatinine, Uric Acid, and Renal Function 2.5 Liver Function Tests, Bilirubin Metabolism, and Jaundice

3 Chapter 3: Clinical Chemistry: Electrolytes, Blood Gases, Enzymology, Endocrinology, and Toxicology

3.1 Water Balance, Electrolytes, Osmolality, and Anion Gap Calculations 3.2 Blood Gas Analysis, Oxygenation, and Acid-Base Homeostasis 3.3 Clinical Enzymology: Enzyme Kinetics, Cardiac Biomarkers, and Hepatic and Pancreatic Enzymes 3.4 Endocrinology: Hormone Physiology and Endocrine Function Testing 3.5 Therapeutic Drug Monitoring and Clinical Toxicology

4 Chapter 4: Bacteriology: Specimen Management, Media, Staining, and Biosafety

4.1 Specimen Collection, Transport, Processing, and Microscopic Staining 4.2 Culture Media Classification, Quality Control, and Inoculation Techniques 4.3 Sterilization, Disinfection, Decontamination, and Biosafety Containment 4.4 Antimicrobial Susceptibility Testing Methods, Standardization, and Resistance Mechanisms

5 Chapter 5: Diagnostic Bacteriology: Major Pathogenic Bacteria

5.1 Medically Important Gram-Positive Cocci: Staphylococci, Streptococci, and Enterococci 5.2 Medically Important Gram-Negative Bacilli: Enterobacterales and Non-Fermenters 5.3 Fastidious, Microaerophilic, and Anaerobic Bacteria 5.4 Mycobacteria, Spirochetes, Atypical Bacteria, and Public Health Microbiology

6 Chapter 6: Medical Parasitology, Mycology, and Diagnostic Virology

6.1 Stool Examination Techniques and Intestinal Nematodes 6.2 Tissue Nematodes, Filarial Worms, Cestodes, and Trematodes 6.3 Medical Protozoology: Intestinal, Urogenital, and Blood/Tissue Protozoa 6.4 Medical Mycology: Yeasts, Dermatophytes, Dimorphic Fungi, and Opportunistic Molds 6.5 Clinical Virology: Viral Structure, Specimen Handling, and Diagnostic Methods

7 Chapter 7: Hematology: Specimen Collection, Routine Parameters, Instrumentation, and Manual Methods

7.1 Blood Specimen Collection, Anticoagulants, Preanalytical Variables, and Specimen Quality 7.2 Automated Cell Counting Principles, Complete Blood Count Parameters, and Erythrocyte Indices 7.3 Reticulocyte Evaluation, Supravital Staining, and Erythrocyte Sedimentation Rate 7.4 Manual Cell Counts, Manual Hemoglobin Methods, and Hematology Quality Control

8 Chapter 8: Hematology: Blood Cell Morphology, Bone Marrow, and Hematologic Disorders

8.1 Normal Erythropoiesis and Erythrocyte Morphologic Abnormalities 8.2 Anemias: Classification, Iron Deficiency, Megaloblastic, Hemolytic, and Hemoglobinopathies 8.3 Normal Leukopoiesis, Leukocyte Differential, and Non-Malignant White Cell Alterations 8.4 Hematologic Malignancies: Acute and Chronic Leukemias, Myeloproliferative and Lymphoproliferative Disorders 8.5 Peripheral Blood Smear Preparation and Staining, Bone Marrow Examination, and Cytochemistry

9 Chapter 9: Hemostasis: Coagulation and Platelet Function Testing and Hemostatic Disorders

9.1 Mechanisms of Primary and Secondary Hemostasis, Fibrinolysis, and Natural Inhibitors 9.2 Coagulation Laboratory Testing: PT/INR, aPTT, Fibrinogen, Thrombin Time, and Mixing Studies 9.3 Hemostatic and Thrombotic Disorders: Hemophilias, von Willebrand Disease, DIC, and Thrombophilias 9.4 Bleeding Time, Clotting Time, Platelet Function, and Special Hematology Tests

10 Chapter 10: Immunohematology: Blood Group Systems and Antiglobulin Testing

10.1 The ABO Blood Group System, Genetics, Subgroups, and Forward/Reverse Typing Discrepancies 10.2 The Rh Blood Group System, Weak D Testing, and Other Major Blood Group Systems 10.3 Antiglobulin Testing, Elution, Adsorption, and Special Antibody Procedures

11 Chapter 11: Blood Banking: Donor Operations, Component Therapy, and Adverse Reactions

11.1 Donor Selection, Physical Examination, Screening, and Mandatory Infectious Marker Testing 11.2 Blood Component Preparation, Storage, Expiration, and Indications for Transfusion 11.3 Pre-Transfusion Compatibility Testing and Transfusion Reactions 11.4 Hemolytic Disease of the Fetus and Newborn (HDFN) and Rh Immune Globulin

12 Chapter 12: Clinical Serology and Immunology

12.1 Principles of Immunology: Antigens, Antibodies, Complement, and Immune Responses 12.2 Serologic Testing Methodologies: Agglutination, Precipitation, Flocculation, and Labeled Immunoassays 12.3 Infectious Disease Serology: Syphilis, Viral Hepatitis Markers, HIV, Dengue, and Febrile Agglutinins 12.4 Autoimmune Serology, Hypersensitivity, Immunodeficiencies, and Histocompatibility (HLA)

13 Chapter 13: Clinical Microscopy: Urinalysis and Renal Pathology

13.1 Renal Physiology, Urine Formation, and Physical Examination of Urine 13.2 Chemical Examination of Urine: Reagent Strip Principles, Interferences, and Confirmatory Tests 13.3 Microscopic Examination of Urine Sediment: Cells, Casts, Crystals, and Contaminants 13.4 Renal Calculi, Glomerular/Tubular/Interstitial Renal Diseases, and Urinalysis Quality Control

14 Chapter 14: Clinical Microscopy: Body Fluids, Fecal Analysis, and Gastric, Duodenal, and Respiratory Specimens

14.1 Cerebrospinal Fluid Analysis: Collection, Cell Counts, Chemistry, and Microbiology 14.2 Serous Fluids (Pleural, Pericardial, Peritoneal: Transudates vs Exudates) and Synovial Fluid Analysis 14.3 Seminal Fluid and Amniotic Fluid Analysis 14.4 Fecal Analysis: Macroscopic, Microscopic, and Chemical Examination of Stool 14.5 Gastric Fluid, Duodenal Contents, Sputum, and Bronchoalveolar Specimens

15 Chapter 15: Histopathologic Techniques and Cytotechnology

15.1 Tissue Preservation, Fixation, Decalcification, and Processing Steps 15.2 Microtomy, Sectioning Artifacts, Hematoxylin and Eosin Staining, and Special Stains 15.3 Cytotechnology: Specimen Collection, Fixation, Papanicolaou Staining, and the Bethesda System 15.4 Special Procedures: Frozen Sections, Special Embedding, Immunohistochemistry, Electron Microscopy, Autopsy, Museum Techniques, and Laboratory Records

16 Chapter 16: Medical Technology Laws, Related Laws, and Ethics

16.1 Republic Act No. 5527 (The Philippine Medical Technology Act of 1969) and Key Amendments 16.2 Related Philippine Healthcare Laws, Code of Ethics, and Bioethics

2.5 Liver Function Tests, Bilirubin Metabolism, and Jaundice

Key Takeaways Explain This Topic AI

Unconjugated bilirubin travels bound to albumin and never appears in urine, while water-soluble conjugated bilirubin is filtered into urine.

The Jendrassik-Grof method uses caffeine-sodium benzoate as accelerator, ascorbic acid to stop the reaction, and alkaline tartrate to form blue azobilirubin.

Obstructive jaundice shows high conjugated bilirubin, positive urine bilirubin, absent urine urobilinogen, acholic stool, and markedly raised ALP and GGT.

Jaundice in the first 24 hours of life is never physiologic and suggests hemolysis such as HDFN or G6PD deficiency.

Blood for ammonia is collected in heparin or EDTA, placed on ice, and analyzed within about 30 minutes because ammonia rises in standing blood.

Last updated: October 2026

Liver Function Tests, Bilirubin Metabolism, and Jaundice

The liver is examined from several directions in Clinical Chemistry: enzymes released by injured cells (covered in the enzymology section), proteins it synthesizes (covered in the protein section), and the substances it clears, above all bilirubin and ammonia . This section covers bilirubin metabolism and measurement, the laboratory classification of jaundice, inherited and neonatal hyperbilirubinemias, ammonia testing, and how the tests combine into liver injury patterns.

1. Bilirubin Metabolism

Formation: About 80% of bilirubin comes from hemoglobin of aged red cells broken down in macrophages of the spleen, liver, and bone marrow. Heme oxygenase opens the heme ring to form biliverdin (green), releasing iron and carbon monoxide. Biliverdin reductase converts biliverdin to unconjugated bilirubin (orange-yellow).

Transport: Unconjugated bilirubin is insoluble in water, so it travels bound to albumin . It cannot be filtered by the glomerulus and does not appear in urine.

Hepatic uptake and conjugation: Hepatocytes take up bilirubin and conjugate it with glucuronic acid using uridine diphosphate glucuronosyltransferase (UGT1A1) , forming mainly bilirubin diglucuronide. Conjugated bilirubin is water-soluble.

Excretion: Conjugated bilirubin is secreted into bile through the canalicular transporter MRP2. This is the rate-limiting step.

Intestinal conversion: Colonic bacteria reduce bilirubin to urobilinogen . Most is oxidized to stercobilin (and urobilin), which colors stool brown. About 10% to 20% of urobilinogen is reabsorbed; most returns to the liver (enterohepatic circulation), and a small amount is excreted in urine.

Delta bilirubin is conjugated bilirubin covalently bound to albumin. It forms in prolonged cholestasis, reacts as direct bilirubin, and persists with albumin's half-life (about 2 to 3 weeks), so total bilirubin can stay high for weeks after an obstruction is relieved.

  • 2. Measuring Bilirubin
  • Diazo Methods

Bilirubin reacts with diazotized sulfanilic acid to form azobilirubin . Conjugated bilirubin reacts directly in water ("direct" bilirubin); unconjugated bilirubin needs an accelerator to be released from albumin.

Method Accelerator Key Features

Evelyn-Malloy Methanol Acid pH; pink-purple azobilirubin read near 560 nm; more affected by hemolysis and turbidity

Jendrassik-Grof Caffeine-sodium benzoate Ascorbic acid stops the diazo reaction and destroys excess reagent; alkaline tartrate converts azobilirubin to a blue form read near 600 nm; more sensitive and less affected by hemoglobin and pH

Direct bilirubin measures conjugated plus delta bilirubin. Indirect (unconjugated) bilirubin = total bilirubin - direct bilirubin.

Specimen handling: Bilirubin is destroyed by light, especially sunlight and phototherapy lamps, so specimens are protected with amber tubes or foil and tested promptly. Hemolysis interferes with diazo methods.

Neonatal bilirubin can be measured by direct spectrophotometry (bilirubinometer), because newborn plasma has little interfering carotene. Transcutaneous bilirubin meters are used for screening.

Reference values (adult): Total bilirubin about 0.2 to 1.0 mg/dL; direct bilirubin up to about 0.2 to 0.3 mg/dL. Multiply mg/dL by 17.1 to convert to µmol/L. Jaundice becomes visible when total bilirubin rises above about 2.5 to 3.0 mg/dL.

3. Laboratory Classification of Jaundice

  • Feature Prehepatic (Hemolytic) Hepatic (Hepatocellular) Posthepatic (Obstructive)
  • Main serum bilirubin Unconjugated Both fractions Conjugated
  • Urine bilirubin Negative Positive Positive
  • Urine urobilinogen Increased Increased or normal Decreased or absent
  • Stool color Normal or dark Normal or pale Pale (acholic, clay-colored)
  • ALT / AST Normal Markedly increased Normal or mildly increased
  • ALP / GGT Normal Normal or mildly increased Markedly increased

Examples Hemolytic anemias, G6PD deficiency crisis, ineffective erythropoiesis Viral hepatitis, drug or alcohol injury, cirrhosis Gallstones, carcinoma of the pancreatic head, biliary atresia

The urine findings follow directly from metabolism: only conjugated bilirubin is filtered into urine, and urobilinogen depends on bilirubin reaching the gut.

4. Inherited and Neonatal Hyperbilirubinemias

Disorder Defect Bilirubin Fraction Notes

Gilbert syndrome Mildly reduced UGT1A1 activity Unconjugated Common and benign; bilirubin rises with fasting, stress, or illness

Crigler-Najjar type I Absent UGT1A1 activity Unconjugated (very high) Kernicterus risk; no response to phenobarbital

  • Crigler-Najjar type II Severely reduced UGT1A1 activity Unconjugated Bilirubin falls with phenobarbital
  • Dubin-Johnson syndrome Defective MRP2 canalicular secretion Conjugated Black pigmented liver; benign
  • Rotor syndrome Defective hepatic storage and reuptake Conjugated Normal liver color; benign

Physiologic jaundice of the newborn is unconjugated hyperbilirubinemia from a high red cell turnover and immature UGT1A1. It appears after the first 24 hours of life and resolves within about 1 to 2 weeks.

Jaundice in the first 24 hours is never physiologic and suggests hemolysis (for example, HDFN or G6PD deficiency, which is common in the Philippines and included in newborn screening).

Very high unconjugated bilirubin crosses the immature blood-brain barrier and causes kernicterus . Treatment is phototherapy, and exchange transfusion when levels are dangerous.

Conjugated hyperbilirubinemia in an infant is always abnormal and suggests biliary atresia or neonatal hepatitis.

5. Ammonia

Ammonia from protein breakdown and intestinal bacteria is converted to urea by the liver's urea cycle . In severe liver failure, portosystemic shunting, Reye syndrome, and inherited urea cycle defects, ammonia rises and contributes to hepatic encephalopathy .

Specimen: Free-flowing venous blood in a heparin or EDTA tube, placed on ice , centrifuged and analyzed within about 30 minutes. Ammonia rises in standing blood as red cells and amino acids release it. Avoid hemolysis and tobacco smoke near the specimen, and avoid ammonium heparin tubes.

Method: The enzymatic glutamate dehydrogenase method measures the decrease in absorbance at 340 nm as NADPH (or NADH) is oxidized while ammonia and alpha-ketoglutarate form glutamate.

6. Putting the Liver Panel Together

Hepatocellular pattern: Large rises in ALT and AST (often more than 10 times the upper reference limit in acute viral or toxic hepatitis) with modest ALP elevation.

Cholestatic pattern: ALP and GGT rise more than the aminotransferases, with conjugated bilirubin and urine bilirubin positive.

Synthetic failure: A falling albumin (slow, because albumin's half-life is about 3 weeks) and a prolonged prothrombin time (fast, because factor VII's half-life is only about 6 hours) show loss of liver function rather than ongoing injury. A prolonged PT that does not correct with vitamin K points to hepatocellular failure rather than vitamin K malabsorption from cholestasis.

Cirrhosis: Low albumin, polyclonal hypergammaglobulinemia with beta-gamma bridging on serum protein electrophoresis, a prolonged PT, low platelets from hypersplenism, and often only mildly raised aminotransferases.